STILAMIN

This brand name is authorized in Brazil, Hong Kong, Singapore, South Africa

Active ingredients

The drug STILAMIN contains one active pharmaceutical ingredient (API):

1 Somatostatin UNII F6R2N217HS - SOMATOSTATIN ACETATE

Somatostatin is a cyclic tetradecapeptide regulating many endocrine and nervous system functions. Somatostatin inhibits release of adenohypophyseal growth hormone, thyrotropin and corticotropin, pancreatic insulin and glucagon, gastric mucosal gastrin, intestinal mucosal secretin, and renal renin by binding to specific somatostatin receptors (SSTR), which are cell surface G protein-coupled receptors expressed in a tissue-specific manner. Read about Somatostatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CB01	Somatostatin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525415120047017, 525418080049903
Country: HK	Department of Health Drug Office	Identifier(s): 33269, 67229
Country: SG	Health Sciences Authority	Identifier(s): 06135P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/21.10/0136